相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advances and Clinical Outcomes of Kidney Transplantation
Charat Thongprayoon et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India
Narayan Prasad et al.
KIDNEY INTERNATIONAL REPORTS (2020)
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients
Megan V. Yanik et al.
PEDIATRIC TRANSPLANTATION (2019)
Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation
Kalluri Thishya et al.
PLOS ONE (2018)
CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
Lucy Chen et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)
Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
Jean-Baptiste Woillard et al.
FRONTIERS IN PHARMACOLOGY (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience
Mona Fathy et al.
BIOMARKERS (2016)
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations
J. T. Tang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Cytochrome and sulfotransferase gene variation in north African populations
Ana Fernandez-Santander et al.
PHARMACOGENOMICS (2016)
The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children
Wafaa Moustafa M. Abo El Fotoh et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease
Yosuke Suzuki et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K. A. Birdwell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase
Karim Aouam et al.
PHARMACOGENOMICS (2015)
Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia
Apolonia Novillo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Frequencies of CYP3A5*1/*3 Variants in a Moroccan Population and Effect on Tacrolimus Daily Dose Requirements in Renal Transplant Patients
Mustapha Elmachad et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids
Jorge R. Ferraris et al.
PEDIATRIC TRANSPLANTATION (2011)
分享论文
